IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q2 2015 Holdings

Filed 2015-08-14 | 27 holdings | $25.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Accuray Inc(ARAY)COM004397105$21.4M3,176,83884.5%
Biogen Inc(BIIB)COM09062X103$3.1M7,72312.3%
Accelerate Diagnostics IncCOM004304200$140.0K5,425,8930.6%
Opko Health Inc(OPK)COM68375N103$79.7K4,959,3350.3%
Quidel CorpCOM74838J101$66.5K2,895,8080.3%
Thoratec CorpCOM NEW885175307$54.8K1,229,6000.2%
Nxstage Medical IncCOM67072V103$51.0K3,572,9630.2%
Chimerix Inc(CMRXEUR)COM16934W106$47.4K1,025,9210.2%
Raptor PharaceuticalsCOM045685659$44.9K2,844,8150.2%
Intrexon CorpCOM46122T102$42.8K876,5020.2%
Hansen Medical IncCOM411307101$41.1K44,918,1910.2%
Mazor Robotics LTDSPONSORED ADS57886P103$32.5K2,439,2370.1%
Agenus IncCOM00847G101$30.9K3,579,5920.1%
Tesaro IncCOM881569107$29.0K493,0000.1%
Acorda Therapeutics IncCOM00484M106$27.2K815,8380.1%
Pacific Biosciences Calif in(PACB)COM69404D108$18.7K3,241,7610.1%
Biolase IncCOM090911108$18.2K10,474,7250.1%
Vermillion IncCOM NEW92407M206$16.8K8,112,1820.1%
Amarin Corp PLCSPONS ADR NEW023111206$12.8K5,184,2250.1%
Webmd Health CorpCOM94770V102$10.5K238,1030.0%
Transition Therapeutics IncCOM NEW893716209$10.2K4,863,9140.0%
Regulus Therapeutics IncCOM75915K101$8.1K741,8040.0%
Contrafect Corp(CFRXEUR)COM212326102$6.2K1,182,0320.0%
Metabolix IncCOM591018809$4.3K1,153,5920.0%
Ziopharm Oncology IncCOM98973P101$2.9K242,1680.0%
Second Sight MED Prods IncCOM81362J100$2.9K210,0000.0%
Ladenburg Thalman FIN Svcs ICOM50575Q102$21060,0000.0%